Monroe Capital provides $20M credit facility to Cytovance Biologics

Monroe Capital was the sole lead arranger and administrative agent for a $20 million senior credit facility funding to sponsor Cytovance Biologics’ growth.

Advertisement

The growth is by private equity sponsor Great Point Partners. Cytovance is based in Oklahoma City and is a contract manufacturing organization of mammalian and microbial biologics. Cytovance supports customers from clinical development to commercial launch in domestic and international markets.

In June, Monroe Capital received funding for $15.5 million senior secured credit facility to support the acquisition of Employee Benefit Solutions by Pharos Capital Group.

More articles on surgery centers:
5 tips for avoiding wrong-site surgery
Creating a healthy ASC culture: 8 perspectives
7 bright ideas for ASC administrators today (and every day)

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.